146 related articles for article (PubMed ID: 33608772)
1. Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.
Verathamjamras C; Sriwitool TE; Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Prasongsook N; Srisomsap C; Svasti J; Champattanachai V
Glycoconj J; 2021 Feb; 38(1):55-65. PubMed ID: 33608772
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine.
Comer FI; Vosseller K; Wells L; Accavitti MA; Hart GW
Anal Biochem; 2001 Jun; 293(2):169-77. PubMed ID: 11399029
[TBL] [Abstract][Full Text] [Related]
3. Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.
Tashima Y; Stanley P
J Biol Chem; 2014 Apr; 289(16):11132-11142. PubMed ID: 24573683
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated.
Lefebvre T; Pinte S; Guérardel C; Deltour S; Martin-Soudant N; Slomianny MC; Michalski JC; Leprince D
Eur J Biochem; 2004 Oct; 271(19):3843-54. PubMed ID: 15373830
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
6. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
7. Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells.
Chaiyawat P; Weeraphan C; Netsirisawan P; Chokchaichamnankit D; Srisomsap C; Svasti J; Champattanachai V
Cancer Genomics Proteomics; 2016 09-10; 13(5):387-98. PubMed ID: 27566657
[TBL] [Abstract][Full Text] [Related]
8. WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins.
Kubota Y; Fujioka K; Takekawa M
PLoS One; 2017; 12(7):e0180714. PubMed ID: 28686627
[TBL] [Abstract][Full Text] [Related]
9. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
Satake K; Shimizu Y; Sasaki Y; Yanagawa H; Suzuki H; Suzuki Y; Horikoshi S; Honda S; Shibuya K; Shibuya A; Tomino Y
BMC Nephrol; 2014 Jun; 15():89. PubMed ID: 24928472
[TBL] [Abstract][Full Text] [Related]
10. Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.
Nagel AK; Schilling M; Comte-Walters S; Berkaw MN; Ball LE
Mol Cell Proteomics; 2013 Apr; 12(4):945-55. PubMed ID: 23443134
[TBL] [Abstract][Full Text] [Related]
11. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
Zachara NE; Cheung WD; Hart GW
Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion.
Netsirisawan P; Chokchaichamnankit D; Srisomsap C; Svasti J; Champattanachai V
Cancer Genomics Proteomics; 2015; 12(4):201-9. PubMed ID: 26136220
[TBL] [Abstract][Full Text] [Related]
13. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
[TBL] [Abstract][Full Text] [Related]
14. Wheat Germ Agglutinin (WGA)-SDS-PAGE: A Novel Method for the Detection of O-GlcNAc-modified Proteins by Lectin Affinity Gel Electrophoresis.
Fujioka K; Kubota Y; Takekawa M
Bio Protoc; 2018 Dec; 8(23):e3098. PubMed ID: 34532545
[TBL] [Abstract][Full Text] [Related]
15. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
17. Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins.
Mullis KG; Haltiwanger RS; Hart GW; Marchase RB; Engler JA
J Virol; 1990 Nov; 64(11):5317-23. PubMed ID: 2120471
[TBL] [Abstract][Full Text] [Related]
18. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
Barratt J; Smith AC; Feehally J
Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
[TBL] [Abstract][Full Text] [Related]
20. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
